In addition, STY39 displayed anti-fibrotic actions like reduced collagen and hydroxyproline content, reduced myofibroblast number and tissue damage, and increased survival
Yue Q, Peng Y, Zhao Y, Lu R, Fu Q, Chen Y, Yang Y, Hai L, Guo L, Wu Y
Lower blood sugar and weight loss can lead to better health and wellness outcomes for people with diabetes, who are at a higher risk for heart disease, stroke, kidney failure, and vision loss
The FDA has not verified the safety, effectiveness, or quality of compounded medications
ISBN 978-0-12-182152-4
Regulatory nodes upstream of Cys involve intermediate metabolites (e.g